Oral alendronate cannot yet be recommended for children with OI
How to Cite
OrthoEvidence. Oral alendronate cannot yet be recommended for children with OI. ACE Report. 2014;3(7):89. Available from: https://myorthoevidene.com/AceReport/Report/5476
Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled studyJ Clin Endocrinol Metab. 2011 Feb;96(2):355-64
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
139 children and adolescents with moderate to severe osteogenesis imperfecta (OI) were randomized to evaluate the safety and efficacy of oral alendronate (ALN). The trial primarily focused on the assessment of lumbar spine bone mineral density (LS BMD) alongside several secondary critera/data: clinical, radiological, biochemical, and multiple bone-related measurements and fracture details. Results...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE